medigraphic.com
Instituto Nacional de Salud Pública

2023, Number 1

<< Back Next >>

salud publica mex 2023; 65 (1)

Cocirculation and replacement of SARS-CoV-2 variants in crowded settings and marginalized populations along the US-Mexico border

Chaillon A, Bojorquez I, Sepulveda J, Harvey-Vera AY, Rangel MG, Skaathun B, Mehta SR, Ignacio C, Porrachia M, Smith DM, Strathdee SA

Language: English
References: 26
Page: 10-18
PDF size: 562.88 Kb.


ABSTRACT

Objective. To interrogate the circulating SARS-CoV-2 lineages and recombinant variants in persons living in migrant shelters and persons who inject drugs (PWID). Materials and methods. We combined data from two studies with marginalized populations (migrants in shelters and persons who inject drugs) in Tijuana, Mexico. SARS-CoV-2 variants were identified on nasal swabs specimens and compared to publicly available genomes sampled in Mexico and California. Results. All but 2 of the 10 lineages identified were predominantly detected in North and Central America. Discrepancies between migrants and PWID can be explained by the temporal emergence and short time span of most of these lineages in the region. Conclusion. The results illustrate the temporo-spatial structure for SARS-CoV-2 lineage dispersal and the potential co-circulation of multiple lineages in high- risk populations with close social contacts. These conditions create the potential for recombination to take place in the California-Baja California border.


REFERENCES

  1. Lemey P, Ruktanonchai N, Hong SL, Colizza V, Poletto C, Van den BroeckF, et al. Untangling introductions and persistence in COVID-19 resurgencein Europe. Nature. 2021;595(7869):713-7. https://doi.org/10.1038/s41586-021-03754-2

  2. Kraemer MUG, Yang CH, Gutierrez B, Wu CH, Klein B, Pigott DM, etal. The effect of human mobility and control measures on the COVID-19epidemic in China. Science. 2020;368(6490):493-7. https://doi.org/10.1126/science.abb4218

  3. Hodcroft EB, Zuber M, Nadeau S, Vaughan TG, Crawford KHD, AlthausCL, et al. Spread of a SARS-CoV-2 variant through Europe in the summerof 2020. Nature. 2021;595(7869):707-12. https://doi.org/10.1038/s41586-021-03677-y

  4. Lemey P, Rambaut A, Bedford T, Faria N, Bielejec F, Baele G, et al.Unifying viral genetics and human transportation data to predict theglobal transmission dynamics of human influenza H3N2. PloS Pathog.2014;10(2):e1003932. https://doi.org/10.1371/journal.ppat.1003932

  5. Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT, Ruis C, et al.A dynamic nomenclature proposal for SARS-CoV-2 lineages to assistgenomic epidemiology. Nat Microbiol. 2020;5(11):1403-7. https://doi.org/10.1038/s41564-020-0770-5

  6. Gutierrez B, Castelan-Sanchez HG, Candido DDS, Jackson B,Fleishon S, Houzet R, et al. Emergence and widespread circulation of a recombinant SARS-CoV-2 lineage in North America. CellHost Microbe. 2022;30(8):1112-23.e3. https://doi.org/10.1016/j.chom.2022.06.010

  7. Upshaw TL, Brown C, Smith R, Perri M, Ziegler C, Pinto AD. Socialdeterminants of COVID-19 incidence and outcomes: A rapid review. PloSOne. 2021;16(3):e0248336. https://doi.org/10.1371/journal.pone.0248336

  8. Hayward SE, Deal A, Cheng C, Crawshaw A, Orcutt M, Vandrevala TF,et al. Clinical outcomes and risk factors for COVID-19 among migrantpopulations in high-income countries: A systematic review. J Migr Health.2021;3:100041. https://doi.org/10.1016/j.jmh.2021.100041

  9. Lebano A, Hamed S, Bradby H, Gil-Salmeron A, Dura-Ferrandis E, Garces-Ferrer J, et al. Migrants’ and refugees’ health status and healthcare inEurope: a scoping literature review. BMC Public Health. 2020;20(1):1039.https://doi.org/10.1186/s12889-020-08749-8

  10. Kondilis E, Papamichail D, McCann S, Orcutt M, Carruthers E, VeizisA, Hargreaves S. The impact of the COVID-19 pandemic on migrants, refugees and asylum Seekers in Greece: A retrospective analysis of nationalsurveillance data from 2020. eClinicalMedicine. 2021;37:100958. https://doi.org/10.1016/j.eclinm.2021.100958

  11. Bojorquez-Chapela I, Strathdee SA, Garfein RS, Benson CA, Chaillon A, Ignacio C, et al. The impact of the COVID-19 pandemic amongmigrants in shelters in Tijuana, Baja California, Mexico. BMJ Global Health.2022;7(3):e007202. https://doi.org/10.1136/bmjgh-2021-007202

  12. Dubey MJ, Ghosh R, Chatterjee S, Biswas P, Chatterjee S, Dubey S. COVID-19 and addiction. Diabetes Metab Syndr. 2020;14(5):817-23. https://doi.org/10.1016/j.dsx.2020.06.008

  13. Aponte-Melendez Y, Mateu-Gelabert P, Fong C, Eckhardt B, Kapadia S,Marks K. The impact of COVID-19 on people who inject drugs in NewYork City: increased risk and decreased access to services. Harm Reduct J.2021;18(1):118. https://doi.org/10.1186/s12954-021-00568-3

  14. Wang QQ, Kaelber DC, Xu R, Volkow ND. COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronichealth records in the United States. Mol Psychiatry. 2021;26(1):30-9.https://doi.org/10.1038/s41380-020-00880-7

  15. Strathdee SA, Abramovitz D, Harvey-Vera A, Vera CF, Rangel G,Artamonova I, et al. Prevalence and correlates of SARS-CoV-2 seropositivity among people who inject drugs in the San Diego-Tijuana borderregion. PloS One. 2021;16(11):e0260286. https://doi.org/10.1371/journal.pone.0260286

  16. Deiss R, Garfein RS, Lozada R, Burgos JL, Brouwer KC, Moser KS,et al. Influences of cross-border mobility on tuberculosis diagnosesand treatment interruption among injection drug users in Tijuana,Mexico. Am J Public Health. 2009;99(8):1491-5. https://doi.org/10.2105/ajph.2008.142166

  17. Melo JS, Mittal ML, Horyniak D, Strathdee SA, Werb D. Injection drug usetrajectories among migrant populations: a narrative review. Subs Use Misuse.2018;53(9):1558-70. https://doi.org/10.1080/10826084.2017.1416404

  18. Goldenberg S, Silverman J, Engstrom D, Bojorquez-Chapela I, StrathdeeS. “Right Here is the Gateway”: Mobility, Sex Work Entry and HIV RiskAlong the Mexico-U.S. Border. Int Migr. 2014;52(4):26-40. https://doi.org/10.1111/imig.12104

  19. Strathdee SA, Lozada R, Ojeda VD, Pollini RA, Brouwer KC, Vera A,et al. Differential effects of migration and deportation on HIV infectionamong male and female injection drug users in Tijuana, Mexico. PLoS One.

  20. 2008;3(7):e2690. https://doi.org/10.1371/journal.pone.000269020. Strathdee SA, Lozada R, Pollini RA, Brouwer KC, Mantsios A, Abramovitz DA, et al. Individual, social, and environmental influences associatedwith HIV infection among injection drug users in Tijuana, Mexico. JAcquir Immune Defic Syndr. 2008;47(3):369-76. https://doi.org/10.1097/QAI.0b013e318160d5ae

  21. Rambaut A, Holmes EC, O’Toole Á, Hill V, McCrone JT, Ruis C, et al.A dynamic nomenclature proposal for SARS-CoV-2 lineages to assistgenomic epidemiology. Nature Microbiol. 2020;5(11):1403-7. https://doi.org/10.1038/s41564-020-0770-5

  22. Shu Y, McCauley J. GISAID: Global initiative on sharing all influenzadata - from vision to reality. Euro Surveill. 2017;22(13):30494. https://doi.org/10.2807/1560-7917.ES.2017.22.13.30494

  23. Gutierrez B, Castelán-Sánchez HG, da Silva Candido D, Jackson B,Fleishon S, Ruis C, et al. Emergence and widespread circulation of arecombinant SARS-CoV-2 lineage in North America. Cell Host Microbe.2022;30(8):1112-23. https://doi.org/10.1016/j.chom.2022.06.010

  24. O’Toole Á, Hill V, Pybus OG, Watts A, Bogoch, II, Khan K, et al.Tracking the international spread of SARS-CoV-2 lineages B.1.1.7 andB.1.351/501Y-V2 with grinch. Wellcome Open Res. 2021;6:121. https://doi.org/10.12688/wellcomeopenres.16661.2

  25. Gangavarapu K, Latif A, Mullen J, Alkuzweny M, Hufbauer E, Tsueng G,et al. Outbreak.info genomic reports: scalable and dynamic surveillanceof SARS-CoV-2 variants and mutarions. 2022 [cited May 2022]. Availablefrom: https://outbreak.info/

  26. Argimón S, Abudahab K, Goater RJE, Fedosejev A, Bhai J, Glasner C, et al.Microreact: visualizing and sharing data for genomic epidemiology and phylogeography. Microb Genom. 2016;2(11). https://doi.org/10.1099/mgen.0.000093




2020     |     www.medigraphic.com